February 21, 2003

Stanford U. to Get Share of $55-Million Patent Settlement

Stanford University, too, is getting an unexpected windfall.

It will receive an undisclosed portion of a $55-million settlement won by a drug company claiming that a competitor had infringed on a patent. The properties covered by the patent include a process invented by a Stanford professor.

The ruling by the U.S. Court of Appeals for the Federal Circuit, issued in January, requires Biogen Inc. to pay $55-million to Berlex Laboratories Inc. and ends lengthy litigation between

Digital or Print Subscription

Web Pass

Already have an account? Log In Now.